Catalyst Wire Dossier Catalyst Wire Dossier

Repaglinide Teva

repaglinide · Teva Pharma B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Repaglinide Teva, covering 2025-02-11 to 2025-02-11. Get the full timeline:

Most recent: EMA Authorised: Repaglinide Teva (repaglinide) — Teva Pharma B.V.

See pricing